In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Medtronic Plc (NYSE: MDT) closed the day trading at $87.00 up 1.08% from the previous closing price of $86.07. In other words, the price has increased by $1.08 from its previous closing price. On the day, 8.96 million shares were traded.
Ratios:
For a better understanding of MDT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.41. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on October 10, 2024, Upgraded its rating to Outperform and sets its target price to $105 from $98 previously.
On August 21, 2024, Oppenheimer reiterated its Perform rating and also lowered its target price recommendation from $92 to $94.
UBS Upgraded its Sell to Neutral on August 15, 2024, whereas the target price for the stock was revised from $76 to $90.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 24 ’25 when Wall Brett A. sold 12,437 shares for $90.00 per share. The transaction valued at 1,119,330 led to the insider holds 40,979 shares of the business.
Wall Brett A. bought 12,437 shares of MDT for $1,119,330 on Jan 24 ’25. On Jan 08 ’25, another insider, Wall Brett A., who serves as the EVP & Pres Neuroscience of the company, sold 9,850 shares for $80.41 each. As a result, the insider received 792,038 and left with 40,708 shares of the company.
Valuation Measures:
As of this moment, Medtronic’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.42, and their Forward P/E ratio for the next fiscal year is 14.91. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.36 while its Price-to-Book (P/B) ratio in mrq is 2.26.
Stock Price History:
Over the past 52 weeks, MDT has reached a high of $93.08, while it has fallen to a 52-week low of $75.96. The 50-Day Moving Average of the stock is 1.54%, while the 200-Day Moving Average is calculated to be 2.21%.
Shares Statistics:
A total of 1.28B shares are outstanding, with a floating share count of 1.28B. Insiders hold about 0.14% of the company’s shares, while institutions hold 84.90% stake in the company.
